Home > Drug Search >
  • company_query: Anavex Life Sciences
  •   > 
Drug Filter
Category:
chemistry (35) biology (2)
Status:
Phase Ⅲ (5) Phase Ⅱ (18) Phase Ⅰ (14)
Clinical Stage:
Pending (5) Active (21) Discontinued (11)
Bio-Type:
Vaccine (1) Whole antibody (1)
Indication:
Acute coronary syndrome (ACS) (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (3) Alzheimer's disease (AD) (2) Arthritis (1) Asthma (1) Atherosclerosis (1) Chronic myeloid leukemia (CML ) (2) Chronic obstructive pulmonary disease (COPD) (1) Crohn's disease (1) Cystic fibrosis (CF) (1) Erectile dysfunction (ED) (1) Glioblastoma multiforme (1) HCV infection (1) Heart failure (1) Hepatocellular carcinoma (HCC) (3) HIV infection (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (3) Non-Hodgkin B-cell lymphomas (1) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Prostate cancer (1) Psoriasis (1) Pulmonary arterial hypertension (1) Schizophrenia (1) Small cell lung cancer (SCLC) (1) Solid tumours (8) Colorectal cancer (1) Transfusion-related iron overload (1) Sarcoma (1) Autoimmune diseases (1) Thymic tumor (1) Glioblastoma (1) Prediabetes (1) Plaque psoriasis (1) Allergic asthma (1) Vasomotor symptoms (1) Cough (1) Thelassemia (1) Immunodeficiency disorders (1) Pemphigus vulgaris (1) Scleroderma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top